Oxygen Biotherapeutics to Report 3Q FY2013 Financial Results
Mar 18, 2013 (Close-Up Media via COMTEX) --
Oxygen Biotherapeutics, Inc. announced that the Company plans to report third quarter fiscal year 2013 financial results on Form 10-Q on Monday, March 18.
According to a release, Oxygen's President and Chief Financial Officer Michael Jebsen will host a conference call and live webcast to discuss the results on Tuesday, March 19, at 11 a.m. EDT.
To access the live teleconference, dial (866) 277-1184 (U.S. and Canada) or (617) 597-5360 (international.) The participant pass code is 10084976. A live webcast will be available on our web site oxybiomed.com/investors.htm.
A replay of the webcast will be available on the Oxygen website, or by phone for a limited time. To access the replay by phone, call (888) 286-8010 (U.S. and Canada) or (617) 801-6888 (international). The pass code for the replay is 10065352.
In addition, the company announced that it will hold a Special Meeting of Shareholders on April 26. A preliminary proxy on Form Pre 14A was filed with the Securities and Exchange Commission on March 12. To access a copy of the Form Pre 14A, click here and then click the SEC Filings tab.
Oxygen Biotherapeutics, Inc. is developing medical and cosmetic products that deliver oxygen to tissues in the body.
((Comments on this story may be sent to firstname.lastname@example.org))
[ Back To TMCnet.com's Homepage ]